Trial Profile
A Phase IB/II study to evaluate the safety and efficacy of the addition of cetuximab to standard preoperative chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 19 Jun 2017
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology